Recruitment of HNF4α/SRC-1 to CYP3A4 promoter → 1Enhancement of detoxification; 2Competitive suppression of FXR-SHP signaling → Reduction of BAs toxicity → Delaying the progression of HCC. Here, CYP3A4 is linked to hepatocellular carcinoma.